UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2025
Commission File Number: 001-42020
MAREX GROUP PLC
(Translation of registrant’s name into English)
| 155 Bishopsgate London EC2M 3TQ UnitedKingdom +44 20 7655 6000 | 140 East 45th Street, 10th Floor New York, New York 10017 (212) 618-2800 |
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
Marex Group plc Preliminary Q3 2025 Update
On8 October 2025, Marex Group plc (the “Company”) issued a press release titled “Marex Group plc provides a strong preliminary Q3 trading update”. A copy of the press release is furnished as Exhibit 99.1 herewith.
EXHIBIT INDEX
The following exhibit is furnished as part of this Form 6-K:
| Exhibit No. | Description | |
| 99.1 | Press release dated 8 October 2025 titled “Marex Group plc provides a strong preliminary Q3 trading update” | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,thereunto duly authorized.
| Marex Group plc | ||||||
| Date: 8 October 2025 | By: | /s/ Robert Irvin | ||||
| Robert Irvin | ||||||
| Chief Financial Officer | ||||||